Clinical Trial Update: Fludeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Cervical Heterogenity Imaging Study [NA]

View source ↗

Summary

The clinical trial update reports that a study using FDG PET/CT to image cervical cancer heterogeneity has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Fludeoxyglucose (FDG) (fludeoxyglucose)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Cervical Cancer | NA | Status: COMPLETED